Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“Important to note that Anktiva is added as an adjunct to current therapy, but where we protect the lymphocytes. Grateful to Sean Compton and Ryan Seacrest for bringing awareness to the revelation that with lymphocytes, patients have a better chance of beating cancer. The quote from Sean’s interview is important:
“… a lot of important public information. We’re not here to promote it or encourage it. We’ve asked, ‘What’s the other side of this?’ We’ve asked around. No doctors or anyone has said there are terrible side effects to what he’s encouraging. In fact, there are no side effects. The patient stories are real. One patient in the special had been written off; he got into the program because the doctor said he would die.
There’s nothing we could do. Now, several years in, they cannot find cancer in his body. You saw his throat in the video. If this is the beginning of an opportunity for many people — especially if caught early – it all started with a call from Ryan Seacrest just to let me know his dad was sick. We were catching up because we hadn’t talked in years.’ ”
More posts featuring Pat Soon-Shiong on OncoDaily.